Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Genet Dev. 1999 Feb;9(1):49-54.

    Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation.

    Source

    Friedrich Miescher Institute, Maulbeerstrasse 66, CH-4058, Basel, Switzerland.

    Abstract

    Mitogenic and nutritional signals must be integrated for a cell to grow. The target of rapamycin (TOR) is emerging as an effector for signals which indicate to the cell whether the external environment is conducive for growth. Use of the immunosuppressant rapamycin, a bacterial macrolide, has been instructive in identifying potential signaling components downstream of TOR, leading to the observation that both protein synthesis and turnover are under TOR control. The central issues concerning TOR are the identification of the proliferative and anti-proliferative signals which mediate its function and the mechanisms by which these signals are transduced to downstream molecules.

    PMID:
    10072357
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk